Ann: MedAdvisor 1H FY23 Investor Webinar, page-2

  1. 3,279 Posts.
    lightbulb Created with Sketch. 1232

    Could this be the 1st profitable half EVER for this company.......good time to become the CEO and CFO

    The outlook was not great given they flagged FY2024 in their pathway to profitability, but the best time to start is right now (yes probably still a lot of costs in digitising the US business and also standardising the platform etc, but they got a pretty decent cash inflow last quarter so they can try to fast track that).

    Incidentally, spoke to a couple of pharmacists a few weeks ago and both said that parts of the app is really useful, but they both said they can do a lot more. Also both were pleasantly surprised at how cheap the cost was......if I can't make the call, I hope someone asks the question (with ~80-90% of the market in Australia, why can't they make money!!!).

    Also was told that the guild app was useless, but at a minimum the purchase took out a competitor and you'd have to think that MDR in Australia are a default to discuss anything digital in relation to medication/users.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.7¢
Change
-0.003(3.75%)
Mkt cap ! $48.14M
Open High Low Value Volume
8.0¢ 8.0¢ 7.7¢ $41.22K 531.9K

Buyers (Bids)

No. Vol. Price($)
3 56330 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 41148 2
View Market Depth
Last trade - 15.44pm 28/07/2025 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.